Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia

被引:59
作者
Camicioli, RM
Korzan, JR
Foster, SL
Fisher, NJ
Emery, DJ
Bastos, AC
Hanstock, CC
机构
[1] Univ Alberta, Glenrose Rehabil Hosp, Dept Med, Div Neurol, Edmonton, AB T5G 0B7, Canada
[2] Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB T6G 2M7, Canada
[3] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2M7, Canada
[4] Univ Alberta, Div Neurosci, Edmonton, AB T6G 2M7, Canada
基金
加拿大健康研究院;
关键词
Parkinson's disease; memory; magnetic resonance imaging; magnetic resonance spectroscopy; hippocampus; cingulate gyrus;
D O I
10.1016/j.neulet.2003.09.076
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The basis for cognitive deficits in Parkinson's disease (PD) is unknown. Hippocampal atrophy has been shown in Alzheimer's disease (AD) and PD. N-Acetyl aspartate (NAA)/creatine (Cr) ratio in the posterior cingulate gyrus (PCG) is decreased in AD, but unknown in PD. Volumetric magnetic resonance (MR) imaging (at 1.5 T) determined corrected HC volume and MR spectroscopy (MRS) PCG metabolites in 12 non-demented mild to moderately affected PD patients (six male, six female) and ten controls (five male, five female). Age (PD = 60.6 years, control = 62.2; P = 0.62), education (PD = 14.1 years, controls = 118; P = 0.89) and global cognition (Mini-Mental State Exam score: PD = 28.7, controls = 29.6; P = 0.14) did not differ. Only recall (CVLT-II, P = 0.046) and NAA/Cr (PD = 1.53, controls = 1.78; P = 0.03) were decreased in PD. Memory correlated with NAA/Cr (r = 0.65, P = 0.02) in PD. In conclusion, cingulate metabolic changes occur in PD. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:177 / 180
页数:4
相关论文
共 19 条
[1]   Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392
[2]   Proton magnetic resonance spectroscopy of patients with parkinsonism [J].
Abe, K ;
Terakawa, H ;
Takanashi, M ;
Watanabe, Y ;
Tanaka, H ;
Fujita, N ;
Hirabuki, N ;
Yanagihara, T .
BRAIN RESEARCH BULLETIN, 2000, 52 (06) :589-595
[3]  
BOWEN BC, 1995, AM J NEURORADIOL, V16, P61
[4]   Parkinson's disease is associated with hippocampal atrophy [J].
Camicioli, R ;
Moore, MM ;
Kinney, A ;
Corbridge, E ;
Glassberg, K ;
Kaye, JA .
MOVEMENT DISORDERS, 2003, 18 (07) :784-790
[5]   Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy [J].
Cordato, NJ ;
Pantelis, C ;
Halliday, GM ;
Velakoulis, D ;
Wood, SJ ;
Stuart, GW ;
Currie, J ;
Soo, M ;
Olivieri, G ;
Broe, GA ;
Morris, JGL .
BRAIN, 2002, 125 :789-800
[6]   The FAB - A frontal assessment battery at bedside [J].
Dubois, B ;
Slachevsky, A ;
Litvan, I ;
Pillon, B .
NEUROLOGY, 2000, 55 (11) :1621-1626
[7]   Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis [J].
Hanstock, CC ;
Cwik, VA ;
Martin, WRW .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 198 (1-2) :37-41
[8]   Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study [J].
Hu, MTM ;
Taylor-Robinson, SD ;
Chaudhuri, KR ;
Bell, JD ;
Morris, RG ;
Clough, C ;
Brooks, DJ ;
Turjanski, N .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (01) :20-26
[9]   Cortical dysfunction in non-demented Parkinson's disease patients -: A combined 31P-MRS and 18FDG-PET study [J].
Hu, MTM ;
Taylor-Robinson, SD ;
Chaudhuri, KR ;
Bell, JD ;
Labbé, C ;
Cunningham, VJ ;
Koepp, MJ ;
Hammers, A ;
Morris, RG ;
Turjanski, N ;
Brooks, DJ .
BRAIN, 2000, 123 :340-352
[10]   1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease [J].
Kantarci, K ;
Smith, GE ;
Ivnik, RJ ;
Petersen, RC ;
Boeve, BF ;
Knopman, DS ;
Tangalos, EG ;
Jack, CR .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2002, 8 (07) :934-942